The use of latanoprost 0.005% Once daily and its effect on intraocular pressure as primary or adjunctive therapy

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 1, 1999, Pages 29-39

  Smith, Shannon L ^a   Sine, Cheryl S ^b   Pruitt, Caroline A ^b   Stewart, William C ^b,c  

^a Lehmann Eye Center   (United States)

^b University of South Carolina   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; MUSCARINIC AGENT; PILOCARPINE;

ADJUVANT THERAPY; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRURITUS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0033007938     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.29     Document Type: Article

References (19)

1. Stewart, W.C. Current and future glaucoma therapy. Ciba Clinical Symposium, 1997, p. 1-43.
2. Stewart, W.C. Prostaglandin analogues: their usage and benefits in glaucoma treatment. Ophthalmic Practice, 14:48-55, 1996.
3. Friström, B. and Nilsson, S.E.G. Intersection of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Arch. Ophthalmol., 111:662-665, 1993.
4. Hoyng, P.F., Rulo, A., Greve, E., Watson, P., and Alm, A. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. Surv. Ophthalmol., 41:S93-S98, 1997.
5. Book, S.A. Essentials of Statistics. McGraw Hill Book Company, New York, 1978, pp. 117-122, 205-215.
6. Rosner, B. Fundamentals of Biostatistics. Duxbury Press, Boston, 1982, p. 301-304.
7. Moses, L.E., Emerson, J.D., and Hosseini, H. Statistics in practice. Analyzing data from ordered categories. New Engl. J. Med., 311:442-448, 1984.
8. Watson, P.G., Stjernschantz, J., and the Latanoprost Study Group. A six-month, randomized double-masked study comparing latanoprost with timolol on open-angle glaucoma and ocular hypertension. Ophthalmology, 103:126-137, 1996.
9. Camras, C.B. and the United States Study Group. Comparison of latanoprost in patients with ocular hypertension and glaucoma. Ophthalmology, 103:138-147, 1996.
10. Nilsson, S.F.E., Samuelsson, M., Bill, A., and Stjernschantz, J. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2a-1-isopropylester in the cynomolgus monkey. Exp. Eye Res., 48:707-716, 1989.
11. Alm, A., Widengård, I., Kjellgren, D., Soderstrom, M., Fristrom, B., Heijl, A., and Stjernschantz, J. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br. J. Ophthalmol., 79:12-16, 1994.
12. 2α analogue, and timolol in patients with elevated intraocular pressure. Br. J. Ophthalmol, 78:899-902, 1994.
13. Barany, E.H. A pharmacologist looks at medical treatment in glaucoma - in retrospect and in prospect. Ophthalmology, 86:80-94, 1979.
14. Grierson, I., Lee, W.R., and Abraham, S. Effects of pilocarpine on the morphology of the human outflow apparatus. Br. J. Ophthalmol., 62:302-313, 1978.
15. Bill, A. and Wålinder, P.E. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest. Ophthalmol., 5:170-175, 1966.
16. Bill, A. and Philips, C.I. Uveoscleral drainage of aqueous humor in human eyes. Exp. Eye Res., 12:275-281, 1971.
17. Shields, M.B. Textbook of Glaucoma. Williams & Wilkins, Baltimore, 1987, pp. 416-422.
18. Krupin, T., Podos, S.M., Eehman, R.A.W., and Becker, B. Effects of optic nerve transection on intraocular pressure in monkeys. Arch. Ophthalmol., 84:668-671, 1970.
19. Patelska, B., Greenfield, D.S., Liebmann, J.M., Wand, M., Kushnick, H., and Ritch, R. Latanoprost 7 for uncontrolled glaucoma in a compassionate case protocol. Am. J. Ophthalmol., 124:279-286, 1997.